Home » Topics » Regulatory » Patents

Patents
RSS

Sunshine Lake Pharma and Calitor Sciences disclose PI3Kdelta inhibitors

Sep. 13, 2016

SK Biopharmaceuticals patents mGlu5 receptor PAMs

Sep. 13, 2016

Sage Therapeutics announces GABA(A) receptor modulators

Sep. 12, 2016

Incyte presents FGFR-4 inhibitors

Sep. 12, 2016

Bristol-Myers Squibb develops NS5B inhibitors

Sep. 12, 2016

Palobiofarma describes adenosine A2B antagonists and melatonin MT3 receptor ligands

Sep. 12, 2016

Acesys Pharmatech discloses antibacterial agents

Sep. 12, 2016

Ligand Pharmaceuticals patents gemcitabine derivatives

Sep. 12, 2016

Curtana Pharmaceuticals describes new Oligo2 inhibitors

Sep. 9, 2016

Lycera presents novel Rho-associated protein kinase 2 inhibitors

Sep. 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...